
Metabolome alterations: a tool to assess efficacy in clinical trials for neuronopathic lysosomal disorders?
Author(s) -
Roberto Giugliani,
Guilherme Baldo
Publication year - 2017
Publication title -
biotarget
Language(s) - English
Resource type - Journals
ISSN - 2522-669X
DOI - 10.21037/biotarget.2017.08.03
Subject(s) - clinical trial , metabolome , disease , natural history , function (biology) , medicine , bioinformatics , psychology , biology , pathology , metabolomics , genetics